FOR U.S. RESIDENTS ONLY
Sculptra® (injectable poly-L-lactic acid)

Healthcare Provider Quick Search
Enter your zip code to search for a healthcare provider near you.
 
Search by street address
 
Site (keyword) Providers (zip code)
For Healthcare Professionals

Sculptra® works to stimulate a progressive increase in dermal thickness3,4

Sculptra® induces an immediate, local reaction which is followed by a progressive increase in volume.

  • In one study, Sculptra® provided a near 3-fold increase from baseline in mean dermal thickness4

Sculptra® induces an immediate, local reaction which is followed by a progressive increase in volume.

  • All of the patients markedly improved from baseline4

  • Statistically significant increases in mean dermal thickness persisted throughout the 2-year study.1

Sculptra® is injected into the skin for restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus.

IMPORTANT SAFETY INFORMATION
Sculptra® is contraindicated in those individuals who have shown a hypersensitivity to any of its components. Sculptra® should not be injected in areas with active skin infection or inflammation. Avoid injection into the blood vessels.

The most commonly observed adverse event was the delayed occurrence of subcutaneous papules, which were confined to the injection site and were typically palpable, asymptomatic, and non-visible. Visible nodules, with or without inflammation or dyspigmentation, have also been reported. Other adverse events include immediate and transient injection-related events such as bleeding from the injection site, discomfort, erythema or inflammation, ecchymosis, and edema.
For more information, please see Full Product Information for Sculptra®

This site is intended for U.S. residents only. Contact Us | Product Information for Sculptra®

Because health matters